about
description
clinical trial
@en
klinisch onderzoek
@nl
name
Safety of RG2077 in Patients With Multiple Sclerosis
@en
Safety of RG2077 in Patients With Multiple Sclerosis
@nl
type
label
Safety of RG2077 in Patients With Multiple Sclerosis
@en
Safety of RG2077 in Patients With Multiple Sclerosis
@nl
prefLabel
Safety of RG2077 in Patients With Multiple Sclerosis
@en
Safety of RG2077 in Patients With Multiple Sclerosis
@nl
P1476
A Phase I Study: Safety of RG2 ...... g-Remitting Multiple Sclerosis
@en
P3098
NCT00076934
P580
2003-01-01T00:00:00Z